CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 80 enrolled
Drug / intervention
Morphine Sulfate +2 moredrug
Likely dose
Morphine Sulfate 15mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03088826
NCT03088826Phase 2Completed

Comparison of Analgesic Efficacy of Morphine Sulfate Immediate Release (MSIR)/Acetaminophen vs. Oxycodone/Acetaminophen (Percocet) for Acute Pain in Emergency Department Patients

Antonios Likourezos·interventional·Posted Mar 23, 2017·Updated Mar 14, 2022

In Brief

A Phase 2 clinical trial evaluating Morphine Sulfate, Oxycodone, and 1 other intervention for Pain Management. Completed, enrolled 80 participants across 1 site.

Detailed Summary

Oxycodone and Hydrocodone are the most commonly used oral opioid analgesics in the emergency department and in outpatient settings. Both medications have a very high potential for abuse due to the prominence of the euphoric effect (abuse liability) and relative lack of "bad "or "negative" effects (likeability). The highly addictive properties of these medications lead to recurrent ED visits for repetitive dosing and prescribing that may lead to abuse, misuse, development of dependence and addiction, and, most importantly, death due to overdose. In contrast, several research papers demonstrated that administration of MSIR results in similar analgesic efficacy to Oxycodone and Hydrocodone but with significantly less euphoric and rewarding associated effects. In addition, consumption of large doses of MSIR leads to dysphoria, vomiting and sedation ("negative effects"). To the investigators' knowledge, there are no randomized controlled trials in the ED that directly compared analgesic efficacy of MSIR to Percocet

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain Management
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedMar 23, 2017
Enrollment StartAug 18, 2017
Primary CompletionDec 22, 2020
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 9.3 years ago

Interventions

Morphine Sulfatedrug

15mg PO morphine sulfate

Oxycodonedrug

10mg Oxycodone

Acetaminophendrug

650 mg Acetaminophen